Aplastic anemia associated with initiation of nizatidine therapy in ahemodialvsis patient

NAKANO T; KUROIWA T; TSUMITA Y; KANEKO Y; HIROMURA K; UEKI K; NOJIMA Y

Art

J-GLOBAL ID：200902285991201030 Reference number：04A0494502

Aplastic anemia associated with initiation of nizatidine therapy in ahemodialvsis patient

血液透析患者においてニザチジン治療の開始に伴う再生不良性貧血

Publisher site {{ this.onShowPLink() }} Copy service {{ this.onShowCLink("http://jdream3.com/copy/?sid=JGLOBAL&noSystem=1&documentNoArray=04A0494502&COPY=1") }}
Access JDreamⅢ for advanced search and analysis. {{ this.onShowJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0494502&from=J-GLOBAL&jstjournalNo=L3173A") }}

Author (7)： , , , , , ,
Material：
Volume： 8 Issue： 2 Page： 160-162 Publication year： Jun. 2004
JST Material Number： L3173A ISSN： 1342-1751 Document type： Article
Article type：原著論文 Country of issue： Germany, Federal Republic of (DEU) Language： ENGLISH (EN)

,...

To see more with JDream III (charged). {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=04A0494502&from=J-GLOBAL&jstjournalNo=L3173A") }}

Other therapies for urogenital diseases , Drug therapy(=pharmacotherapy)for digestive system diseases , Clinical application of histaminergic drugs and antihistaminergic drugs

Reference (8)：

HOWDEN, CW. The tolerability and safety profile of famotidine. Clin Ther. 1996, 18, 36-54
AYMARD, JP. Haematological adverse effects of histamine H2-receptor antagonists. Med Toxicol Adverse Drug Exp. 1988, 3, 430-448
ABOU-SAIF, A. Gastrointestinal and hepatic disorders in end-stage renal disease and renal transplant recipients. Adv Ren Replace Ther. 2000, 7, 220-230
NARANJO, CA. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981, 30, 239-245
BISWAS, N. Aplastic anemia associated with antithyroid drugs. Am J Med Sci. 1991, 301, 190-194

ｍore...

, , ,

Return to Previous Page